One-line Summary: Distribution by Sony in Japan Leverages Compatibility of Nanovial
Technology with Sony's Flow Cytometry Instruments
LOS
ANGELES, July 1, 2024 /PRNewswire/ -- Partillion
Bioscience Corporation ("Partillion"), a life science tools
company, announced the commercial availability of its portfolio of
single-cell analysis products in Japan. Partillion's Nanovial technology
enables functional single-cell screens directly from secreting
cells, all using standard flow cytometers and flow sorters.
Nanovials are bowl-shaped hydrogel microparticles sized to fit
through flow cytometry instruments. Cells are loaded into the
nanoliter-scale cavities of Nanovials where their secretions can
also be captured, labeled and analyzed. The products available in
Japan include flexible
biotinylated Nanovials for custom assay development, and two
recently released products that accelerate antibody discovery from
mouse antibody-secreting cells. Partillion's products have been
easy to adopt across the world because they leverage standard flow
cytometry instruments, with over 100 customers across academic
institutions, national research centers, pharmaceutical and
biotechnology companies.
Sony Corporation will be the exclusive distributor of
Partillion's products in Japan,
which will allow Partillion to further accelerate adoption in
Japan of Partillion's growing
product portfolio. Products that will be distributed in
Japan include Partillion's
original Nanovial formulation and recently released EZM™
formulation, expanding compatibility to adherent cells while also
improving cell recovery and secretion signal. In addition,
Partillion's Antibody Discovery Kits for mouse hybridoma,
plasmablasts and plasma cells will be available in Japan. These all-in-one kits provide reagents
and protocols to simplify the workflow for customers to screen
hundreds of thousands of antibody-secreting cells in a single day,
using instruments they already have, such as Sony's flow
cytometers. Live cells are recovered suitable for downstream
regrowth or single-cell sequencing.
"Throughout our product development we've seen fantastic
compatibility of Nanovials with Sony's cell sorters and spectral
analyzers," said Joe de Rutte, Co-founder and CEO of
Partillion. "Our customers are often Sony customers, and we can
seamlessly enable new research and drug discovery capabilities for
them, creating huge cost efficiencies and value."
About Partillion
Partillion Bioscience is a venture-backed life science company
developing a next generation single-cell analysis platform.
Partillion's award winning Nanovial technology enables customers to
accelerate therapeutic development to address the most difficult
diseases and provide advanced scientific insights. The
reagent-based platform, with products available at
www.partillion.com, unlocks the ability to screen hundreds of
thousands to millions of individual cells based on critical yet
difficult to probe functional information all while using easy to
access lab equipment – solving a major pain point in the industry.
The technology underpinning Partillion's products was developed in
Dino Di Carlo's lab (UCLA) and has been featured in notable journals
such as Nature Nanotechnology, Nature Communications, Proceedings
of the National Academy of Sciences of the USA, Science Advances, and ACS Nano and
received industry accolades, winning the 2020 SLAS Innovation Award
and 2022 SLAS New Product Award.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/partillion-biosciences-nanovial-products-available-in-japan-through-distribution-by-sony-302186685.html
SOURCE Partillion Bioscience